Brief: Evoke Pharma Strengthens Its Intellectual Property Portfolio With A Notice Of Allowance From The Uspto For A Patent Application Related To Gimoti®
30/11/2022 14:40
Nov 30 (Reuters) - Evoke Pharma Inc EVOK.O :
* EVOKE PHARMA STRENGTHENS ITS INTELLECTUAL PROPERTY
PORTFOLIO
WITH A NOTICE OF ALLOWANCE FROM THE USPTO FOR A PATENT
APPLICATION RELATED TO GIMOTI®
Source text for Eikon: ID:nGNX1PKhVp
Further company coverage: EVOK.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Evoke Pharma
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Evoke Pharma Q3 sales rise 61%, expects QOL Medical acquisition to close in Q4 2025
Brief: Evoke Pharma Enters Into Definitive Agreement To Be Acquired By QOL Medical
Evoke Pharma Inc reports results for the quarter ended June 30 - Earnings Summary